Projected Income Statement: Eurazeo

Forecast Balance Sheet: Eurazeo

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 2,964 4,416 823 1,343 1,141 972 886 520
Change - 48.99% -81.36% 63.18% -15.04% -14.83% -8.85% -41.31%
Announcement Date 25/03/22 06/04/23 07/03/24 28/03/25 30/03/26 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Eurazeo

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 259.8 444.7 12.57 18.18 - 6.7 7.3 7.7
Change - 71.19% -97.17% 44.64% - - 8.96% 5.48%
Free Cash Flow (FCF) 1 213.7 -190.6 -24.18 50.7 123.8 306.6 457.3 521.8
Change - -189.17% 87.31% 309.66% 144.17% 147.69% 49.15% 14.1%
Announcement Date 25/03/22 06/04/23 07/03/24 28/03/25 30/03/26 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Eurazeo

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 16.29% 14.29% 30.43% -82.19% -70.5% 37.91% 157.13% 159.68%
EBIT Margin (%) 9.9% 9.65% 25.85% -86.44% -74.47% 78.55% 103.89% 118.4%
EBT Margin (%) 44.71% 12.35% 540.51% -108.51% -101.13% 24.87% 34.49% 53.95%
Net margin (%) 35.08% 12.82% 530.7% -112.13% -96.26% 46.63% 93.73% 96.81%
FCF margin (%) 4.76% -4.11% -7.04% 13.23% 29.53% 76.46% 92.48% 98.95%
FCF / Net Income (%) 13.56% -32.05% -1.33% -11.8% -30.68% 163.96% 98.66% 102.21%

Profitability

        
ROA - - - - - - - -
ROE 29.09% 9.41% 25.03% -5.6% -5.97% 2.9% 5.71% 6.37%

Financial Health

        
Leverage (Debt/EBITDA) 4.05x 6.66x 7.87x -4.26x -3.86x 6.39x 1.14x 0.62x
Debt / Free cash flow 13.87x -23.17x -34.03x 26.49x 9.22x 3.17x 1.94x 1x

Capital Intensity

        
CAPEX / Current Assets (%) 5.78% 9.58% 3.66% 4.74% - 1.67% 1.48% 1.46%
CAPEX / EBITDA (%) 35.48% 67.05% 12.02% -5.77% - 4.41% 0.94% 0.91%
CAPEX / FCF (%) 121.54% -233.33% -51.99% 35.87% - 2.19% 1.6% 1.48%

Items per share

        
Cash flow per share 1 4.351 3.483 -0.1626 0.9482 1.827 6.312 8.418 12.81
Change - -19.95% -104.67% 683.11% 92.66% 245.51% 33.37% 52.17%
Dividend per Share 1 1.75 2.2 2.42 2.65 2.92 3.16 3.46 3.817
Change - 25.71% 10% 9.5% 10.19% 8.21% 9.5% 10.32%
Book Value Per Share 1 80.34 85.56 110.1 102.5 96.01 93.38 121.8 133.5
Change - 6.5% 28.65% -6.86% -6.35% -2.74% 30.41% 9.59%
EPS 1 21.75 8.22 25.56 -5.95 -5.86 2.8 7.18 8.46
Change - -62.21% 210.95% -123.28% 1.51% 147.78% 156.43% 17.83%
Nbr of stocks (in thousands) 76,494 76,744 74,736 72,219 65,276 63,871 63,871 63,871
Announcement Date 25/03/22 06/04/23 07/03/24 28/03/25 30/03/26 - - -
1EUR
Estimates
2026 *2027 *
P/E 30.9x 7.05x
PBR 0.54x 0.52x
EV / Sales 10.5x 8.33x
Yield 6.24% 6.83%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
50.65EUR
Average target price
69.17EUR
Spread / Average Target
+36.56%

Quarterly revenue - Rate of surprise